One of the recent controversies in olfaction has been the relative contribution of the cAMP and InsP3 (IP3) second messenger pathways in olfactory transduction, especially in vertebrates, and whether individual odorants specifically act via the two pathways. This controversy has been profitably
No takes yet. Share an insight, caveat, or question.
Peter H. Barry (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: